Search results
A Rare Case of Quadricuspid Pulmonary Valve
Author(s):
Christina A Theochari
,
Christos Tountas
,
Nikolaos Tsiamis
,
et al
Added:
2 weeks ago
Medical Image
Perspectives on HI-PEITHO
Author(s):
Dinu Valentin Balanescu
,
Arashk Motiei
,
Riyaz Bashir
Added:
6 days ago
Viewpoint
Author(s):
Molly Silkowski
,
Payton Kendsersky
,
Nicholas Amoroso
Added:
1 year ago
Author(s):
Felix Mahfoud, Ingo Ahrens, Thomas Cuisset ,et al
Start date:
Dec 03, 2024
Join us for an insightful webinar designed to enhance an understanding of the latest developments in pulmonary embolism (PE) management.Moderated by Prof Felix Mahfoud (University Hospital Basel, CH), the faculty will explore current guidelines with a critical eye, particularly where gaps may exist, such as in managing intermediate-risk patients. Featuring findings from the PEERLESS study, this…
View more
Author(s):
David J Cohen
Added:
7 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of…
View more
Author(s):
Devi Nair
,
Laurence Epstein
,
Robert D Schaller
Added:
8 months ago
In this essential episode of Rhythm Interventions Unplugged, host Dr Devi Nair (St. Bernard's Medical Center, US) sits down with two leading experts in cardiac device management: Dr Larry Epstein and Dr Robert Schaller. Together, they explore a critical challenge facing electrophysiologists today - managing pacemaker and ICD leads in patients requiring tricuspid valve interventions.Dr Epstein and…
View more
NY Valves 2025 Late-Breaking Science Collection
Video Series
Author(s):
Thomas Modine
Added:
1 year ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Author(s):
Tanush Gupta
Added:
11 months ago
New York Valves 25 - Dr Tanush Gupta (UVM Medical Center, Burlington, VT, US) joins us to discuss key conversations around lifetime management for transcatheter aortic valve replacement (TAVR) patients. He discusses key data from the NOTION trial and how this has influenced his practice, as well emerging technologies such as AI simulation models and new valves.Interview Questions:How has FDA…
View more
Author(s):
Suzanne Arnold , Colin Barker,
Start date:
Aug 07, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday…
View more